In this study, we have examined the interaction of hyaluronan (HA)-CD44 with IQGAP1 (one of the binding partners for the Rho GTPase Cdc42) in SK-OV-3.ipl human ovarian tumor cells. Immunological and biochemical analyses indicated that IQGAP1 (molecular mass of ϳ190 kDa) is expressed in SK-OV-3.ipl cells and that IQGAP1 interacts directly with Cdc42 in a GTPdependent manner. Both IQGAP1 and Cdc42 were physically linked to CD44 in SK-OV-3.ipl cells following HA stimulation. Furthermore, the HA-CD44-induced Cdc42-IQGAP1 complex regulated cytoskeletal function via a close association with F-actin that led to ovarian tumor cell migration. In addition, the binding of HA to CD44 promoted the association of ERK2 with the IQGAP1 molecule, which stimulated both ERK2 phosphorylation and kinase activity. The activated ERK2 then increased the phosphorylation of both Elk-1 and estrogen receptor-␣ (ER␣), resulting in Elk-1-and estrogen-responsive element-mediated transcriptional up-regulation. Down-regulation of IQ-GAP1 (by treating cells with IQGAP1-specific small interfering RNAs) not only blocked IQGAP1 association with CD44, Cdc42, F-actin, and ERK2 but also abrogated HA-CD44-induced cytoskeletal function, ERK2 signaling (e.g. ERK2 phosphorylation/activity, ERK2-mediated Elk-1/ER␣ phosphorylation, and Elk-1/ ER␣-specific transcriptional activation), and tumor cell migration. Taken together, these findings indicate that HA-CD44 interaction with IQGAP1 serves as a signal integrator by modulating Cdc42 cytoskeletal function, mediating Elk-1-specific transcriptional activation, and coordinating "cross-talk" between a membrane receptor (CD44) and a nuclear hormone receptor (ER␣) signaling pathway during ovarian cancer progression.Ovarian cancer cells are characterized by their ability to freely invade the peritoneal cavity, which is consistent with the well known aggressiveness and high morbidity rate of ovarian tumors (1-3). A number of studies have aimed at identifying specific molecule(s) expressed in ovarian carcinomas that correlate with tumor cell invasive behaviors. Among such candidate molecules is CD44 (a major hyaluronan (HA) 1 receptor) (4), which belongs to a family of multifunctional transmembrane glycoproteins expressed in ovarian tumor cells and carcinoma tissues (5-9). CD44 has been found to interact with HA at the N terminus of its extracellular domain (10 -12). Ovarian cancer cells express CD44 isoforms that cause very strong cell adhesion to HA-enriched peritoneal mesothelium (8,9,13,14). A significant reduction in tumor implants has been found to occur in nude mice 5 weeks after intraperitoneal injection of ovarian cancer cells incubated with anti-CD44 antibody compared with injected cells pretreated with antibodies against other cell-surface proteins (8, 9). These findings suggest that CD44 interaction with HA may be one of the important requirements for the peritoneal spread of ovarian cancer. However, the cellular and molecular mechanisms controlling the ability of CD44-positive ovarian tumor cells to und...